The Library
The future of precise cancer chronotherapeutics
Tools
Innominato, Pasquale F., Karaboué, Abdoulaye, Bouchahda, Mohammed, Bjarnason, Georg A. and Lévi, Francis A. (2022) The future of precise cancer chronotherapeutics. The Lancet Oncology, 23 (6). e242. doi:10.1016/S1470-2045(22)00188-7
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1016/S1470-2045(22)00188-7
Abstract
We have read with great interest the recent comprehensive systematic review on chronomodulated chemotherapy by Markella Printezi and colleagues. 1 An updated critical revision of available evidence was overdue, given that the previous one was published nearly 30 years ago. 2 Although only a small number of randomised controlled clinical trials involving chronomodulated or circadian-based chemotherapy have been done in the interval between these two systematic reviews, two major developments need to be highlighted.
Item Type: | Journal Item | ||||
---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||
Journal or Publication Title: | The Lancet Oncology | ||||
Publisher: | The Lancet Publishing Group | ||||
ISSN: | 1470-2045 | ||||
Official Date: | 1 June 2022 | ||||
Dates: |
|
||||
Volume: | 23 | ||||
Number: | 6 | ||||
Article Number: | e242 | ||||
DOI: | 10.1016/S1470-2045(22)00188-7 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |